Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma

BACKGROUND: The anti-Programmed Death receptor 1 (anti-PD-1) antibodies nivolumab and pembrolizumab are new treatments in metastatic melanoma. Immunotherapies are best known to be responsible for thrombotic microangiopathy. However, immune interstitial nephritis has been described in a patient treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bottlaender, Lea, Breton, Anne-Laure, de Laforcade, Louis, Dijoud, Frederique, Thomas, Luc, Dalle, Stephane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514510/
https://www.ncbi.nlm.nih.gov/pubmed/28716106
http://dx.doi.org/10.1186/s40425-017-0261-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514510/
https://www.ncbi.nlm.nih.gov/pubmed/28716106
http://dx.doi.org/10.1186/s40425-017-0261-2

Ejemplares similares